Indraprastha Medical Corporation Ltd vs Shalby Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 299.95 as of 23 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Shalby Ltd changed from 25.7 on March 2021 to 36.5 on March 2026 . This represents a CAGR of 6.02% over 6 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Shalby Ltd changed from ₹ 1089 crore on March 2021 to ₹ 1370 crore on March 2026 . This represents a CAGR of 3.90% over 6 years The revenue of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shalby Ltd for the Jun '26 is ₹ 338.64 crore as compare to the Mar '26 revenue of ₹ 295.52 crore. This represent the growth of 14.59% The ebitda of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shalby Ltd for the Jun '26 is ₹ 49 crore as compare to the Mar '26 ebitda of ₹ 37.43 crore. This represent the growth of 30.91% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Shalby Ltd changed from ₹ 14.74 crore to ₹ 10.5 crore over 9 quarters. This represents a CAGR of -13.99% The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Shalby Ltd changed from 25.19 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About Shalby Ltd

Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
With 15 hospitals and over 2,300 beds across 12 cities, Shalby is now the largest corporate hospital group in Western and Central India.
The Hospitals are tertiary care hospitals, few of which offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and Shalby Ltd

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Shalby Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr while Market cap of Shalby Ltd is 1,227 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Shalby Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and Shalby Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and Shalby Ltd?

As of October 25, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹299.95. On the other hand, Shalby Ltd stock price is INR ₹113.65.

How do dividend payouts of Indraprastha Medical Corporation Ltd and Shalby Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Shalby Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.